Exploring Novel Technology to Treat Glioma using 1267nm Light: Direct Light Therapy
We are a consortium of 6 partners working together to find better treatment for Glioma using a new Direct Light Therapy (DLT). DLT shines 1267nm light inside the brain to selectively kill cancer cells whilst leaving healthy tissue alive. The GlioLighT project will illuminate how and why this approach works.
Important note: DLT is not an established technology and will not be fit for human use for many years. The GlioLighT project is one of the first steps of an extensive decades-spanning development process before DLT is widely available to individuals suffering from Glioma or other cancers. DLT could be the cancer solution of the future, but regrettably, it is not a solution of the present.
Funded under Horizon Europe EIC Pathfinder programme (No.
101129705). UK participants are funded by UKRI (No. 10110169)
https://gliolight.eu/